Skip to main content

Table 2 Final models for associations between HIV care cascade outcomes and socio-demographic and treatment-related characteristics

From: The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study

 

Available clinical record (n=951)

AOR (95% CI); p value

Available VL data within records (n=878)

AOR (95% CI); p value

VL recorded in past 12 months (n=449)

AOR (95% CI); p value

Most recent VL <1000 copies/mL (n=669)

AOR (95% CI); p value

Most recent VL <50 copies/mL (n=513)

AOR (95% CI); p value

Mortality

   

Rural living

2.13 (1.07–4.27); 0.033

0.66 (0.46–0.93); 0.019

Sex (male)

1.55 (1.05–2.28); 0.026

2.36 (1.28–4.37); 0.006

Age at study enrolment (≥15 years)

0.32 (0.16–0.62); 0.001

0.82 (0.62–1.10); 0.181

  

Sexually infected

1.71 (1.06–2.74); 0.028

0.28 (0.15–0.52); <0.0001

Decentralised care

 

1.39 (1.06–1.83); 0.018

Time on ART (≥2 years)

  

3.42 (2.14–5.47); <0.0001

1.72 (1.09–2.72); 0.020

1.70 (1.12–2.58); 0.013

Age at most recent VL (≥15 years)

   

0.54 (0.39–0.75); <0.0001

0.72 (0.55–0.94); 0.017

  1. AOR Adjusted odds ratio, ART Antiretroviral therapy, CI 95% Confidence interval, VL Viral load
  2. Note: Adjusted odds ratios are only indicated for variables remaining in the final model for each outcome. Empty boxes indicate variables that were not applicable to analyses. Boxes filled with a dash indicate variables not included in the final model because they had failed to reach significance in prior models